Research Article
[Retracted] Clinical Efficacy of Sanfeng Tongqiao Diwan in the Treatment of Allergic Rhinitis: A Randomized Controlled Trial
Table 2
Changes of questionnaire scores before and after treatment in two groups.
| | Study () | Control () | Before therapy | After therapy | | Before therapy | After therapy | |
| Compliance (%) | | | | <0.001 | Total VAS score | | | <0.001 | | | <0.001 | Total symptom relief score | | | <0.001 | | | <0.001 | Total RQLQ score | | | <0.001 | | | <0.001 | Activity limitation | | | <0.001 | | | <0.001 | Sleep problems | | | <0.001 | | | 0.004 | Nonnose/eye symptoms | | | <0.001 | | | <0.001 | Practical problems | | | <0.001 | | | <0.001 | Nose symptoms | | | 0.001 | | | <0.001 | Eye symptoms | | | 0.022 | | | 0.001 | Emotion | | | 0.002 | | | 0.006 | ESS score | | | 0.026 | | | 0.254 |
|
|
Note: VAS: visual analogue scale; RQLQ: Rhinoconjunctivitis Quality of Life Questionnaire; ESS: Epworth sleepiness scale.
|